ClinConnect ClinConnect Logo
Search / Trial NCT06438133

Digital Supported Compression Bandaging in Patients with Chronic Edema in the Lower Limbs

Launched by CARSTEN BOGH JUHL · May 27, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Compression Therapy Compression Bandaging Chronic Edema Psychometrics

ClinConnect Summary

This clinical trial is looking at a new device called CIMON, which helps doctors understand how well compression bandages work for patients with chronic swelling in their lower legs. If you have been experiencing this kind of swelling and have been referred for compression bandaging, you might be eligible to participate. To qualify, you need to have a certain level of swelling in your legs, specifically a measurement between 35-75 cm at the widest part of your lower leg. However, if you have any open wounds, certain infections, or serious heart or kidney issues, you may not be able to take part.

Participants in the study will have the CIMON sensor placed on their leg before they start their usual treatment with compression bandages. This study will last for 14 days, during which you'll receive the standard care based on your swelling's severity. It's an opportunity to contribute to important research that may improve treatment for people with similar conditions in the future. If you're interested, the trial is currently recruiting participants of all genders aged 65 and older.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Chronic edema of the lower limb
  • Referred to compression bandaging
  • Circumference of widest point of the lower leg between 35-75 cm
  • Exclusion Criteria:
  • Wounds at the lower leg (at the widest circumference of the lower leg)
  • Acute deep venous thrombosis in the leg
  • Untreated cellulitis
  • Severe heart- or kidneyfailure
  • Severe peripheral neuropathy in the lower limbs

About Carsten Bogh Juhl

Carsten Bogh Juhl is a dedicated clinical trial sponsor known for advancing innovative research in the healthcare sector. With a strong commitment to improving patient outcomes, Juhl focuses on the design and implementation of rigorous clinical studies that adhere to the highest ethical standards and regulatory guidelines. Leveraging a wealth of expertise in clinical development, Juhl collaborates with a diverse array of stakeholders, including healthcare professionals, regulatory bodies, and research institutions, to foster groundbreaking medical advancements and contribute to the evolution of evidence-based treatments.

Locations

Bispebjerg, Capital Region, Denmark

Copenhagen, Capital Region, Denmark

Herlev, Capital Region, Denmark

Hvidovre, Capital Region, Denmark

Odense, Region Of Southern Denmark, Denmark

Odense, Region Of Southern Denmark, Denmark

Patients applied

0 patients applied

Trial Officials

Carsten Bogh Juhl, Professor

Study Chair

Herlev and Gentofte Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported